Treatment of chronic hepatitis B and C with alpha interferon in a renal transplant patient

Scandinavian Journal of Urology and Nephrology

Volumn 30, Issue 6, 1996, Pages 485-487

  Rostaing, Lionel ^a   Izopet, Jacques ^b   Cisterne, Jean Marc ^a   Baron, Emmanuel ^a   Rumeau, Jean Louis ^a   Chabannier, Marie Hélène ^a   Duffaut, Michel ^a   Durand, Dominique ^a  

^a CHU RANGUEIL   (France)

^b CHU PURPAN   (France)

Author keywords

Alpha interferon; Chronic hepatitis B; Chronic hepatitis C; HBV DNA; Liver enzymes; Renal transplantation

Indexed keywords

ALPHA INTERFERON; AZATHIOPRINE; CYCLOSPORIN A; LIVER ENZYME; PREDNISOLONE; THYMOCYTE ANTIBODY;

ADULT; ARTICLE; CASE REPORT; COMPLICATION; GRAFT REJECTION; HEPATITIS B; HEPATITIS C; HUMAN; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; LEUKOPENIA; MALE; PRIORITY JOURNAL; THROMBOCYTOPENIA; VIRUS REPLICATION;

EID: 0030443651     PISSN: 00365599     EISSN: None     Source Type: Journal    
DOI: 10.3109/00365599609182328     Document Type: Article

References (17)

1. Anuras S, Piros J, Bonney WW, et al. Liver disease in renal transplant recipients. Arch Intern Med 1977; 137: 42.
2. Balart LA, Perrillo R, Roddenberry J, et al. Hepatitis C RNA in liver of chronic hepatitis C patients before and after treatment. Gastroenterology 1993; 104: 1472.
3. Berne TV, Fitzgibbons TJ, Silberman H. The effect of hepatitis B antigenemia on long-term success and hepatic disease in renal transplantation. Transplantation 1977; 24: 412.
4. Boyce, NW, Holdsworth SR, Hooke D, Thomson NM, Atkins RC. Non-hepatitis B associated liver disease in a renal transplant population. Am J Kidney Dis 1988; 11: 307.
5. Chan TM, Lok ASF, Cheng IKP, et al. A prospective study on hepatitis C virus infection among renal transplant recipients. Hepatology 1993; 17: 5.
6. Degos F. Hepatites virales au cours de l'hémodialyse chronique et de la transplantation rénale. Gastroentérol Clin Biol 1983; 7: 923.
7. Dusheiko G, Song E, Bowiers S, et al. Natural history of hepatitis B virus infection in renal transplant recipients. A fifteen-year follow-up. Hepatology 1983; 3: 330.
8. Huang CC, Liaw YF, Lai MK, et al. The clinical outcome of hepatitis C virus antibody-positive renal allograft recipients. Transplantation 1992; 53: 763.
9. Korenman J, Baker B, Waggoner J, et al. Long-term remission of chronic hepatitis B after alpha-interferon therapy. Ann Int Med 1991; 114: 629.
10. Pirson Y, Alexandere GPJ, Van Ypersele de Strihou C. Long-term effect of HBs antigenemia on patient survival after renal transplantation. N Engl J Med 1977; 296: 194.
11. Rostaing L, Izopet J, Baron E, Duffaut M, Puel J, Durand D. Treatment of chronic hepatitis C with recombinant interferon alpha in kidney transplant recipients. Transplantation 1995; 59: 1426.
12. Roth D, Zucker K, Cirocco R, et al. The impact of hepatitis virus infection on renal allograft recipients. Kidney Int 1994; 45: 238.
13. Saracco G, Rosina F, Abate ML, et al. Long-term follow-up of patients with chronic hepatitis C treated with different doses of interferon-α2b. Hepatology 1993; 18: 1300.
14. Sengar DPS, Couture RA, Lazarovits AI, Jindal SL. Long-term patient and renal allograft survival in HBS Ag infection. Transplant Proc 1989; 21: 3358.
15. Shindo M, Di Bisceglie AM, Cheung L. Decrease in serum hepatitis C viral RNA during alpha-interferon therapy for chronic hepatitis C. Ann Intern Med 1991; 115: 700.
16. Ware AJ, Luby JP, Hollinger B, et al. Etiology of liver disease in renal transplant patients. Ann Intern Med 1979; 91: 364.
17. Wong DKH, Cheung AM, O'Rourke K, et al. Effect of alpha-interferon treatment in patients with hepatitis B antigen-positive chronic hepatitis B. A meta-analysis. Ann Intern Med 1993; 119: 312.